Journal of Biological Chemistry · 2007 · 90 citations · 24 references
Life SciencesCell BiologyMolecular BiologyCell SignalingNeoplasiaSignal TransductionCancer Cell SignalingGrowth Factor SignalingMitogenic SignalingOncogenic Signaling PathwaysSquamous Cell CarcinomaAnnexin A1Epidermal Growth Factor Receptor SignalingPhospholipase A2 Pathway
Regulation of cell growth and apoptosis is one of the pleiotropic functions of annexin A1 (ANXA1). Although previous reports on the overexpression of ANXA1 in many human cancers and on growth suppression and/or induction of apoptosis by ANXA1 may indicate the tumor-suppressive nature of ANXA1, molecular mechanisms of the function of ANXA1 remain largely unknown. Here we provide evidence that ANXA1 mechanistically links the epidermal growth factor-triggered growth signal pathway with cytosolic phospholipase A2 (cPLA2), an initiator enzyme of the arachidonic acid cascade, through interaction with S100A11 in normal human keratinocytes (NHK). Ca2+-dependent binding of S100A11 to ANXA1 facilitated the binding of the latter to cPLA2, resulting in inhibition of cPLA2 activity, which is essential for the growth of NHK. On exposure of NHK to epidermal growth factor, ANXA1 was cleaved solely and was by pathway was to may for human and cell growth Regulation of cell growth and apoptosis is one of the pleiotropic functions of annexin A1 (ANXA1). Although previous reports on the overexpression of ANXA1 in many human cancers and on growth suppression and/or induction of apoptosis by ANXA1 may indicate the tumor-suppressive nature of ANXA1, molecular mechanisms of the function of ANXA1 remain largely unknown. Here we provide evidence that ANXA1 mechanistically links the epidermal growth factor-triggered growth signal pathway with cytosolic phospholipase A2 (cPLA2), an initiator enzyme of the arachidonic acid cascade, through interaction with S100A11 in normal human keratinocytes (NHK). Ca2+-dependent binding of S100A11 to ANXA1 facilitated the binding of the latter to cPLA2, resulting in inhibition of cPLA2 activity, which is essential for the growth of NHK. On exposure of NHK to epidermal growth factor, ANXA1 was cleaved solely and was by pathway was to may for human and cell growth A1 ANXA1, annexin normal human epidermal growth growth cPLA2, cytosolic phospholipase ANXA1, annexin normal human epidermal growth growth cPLA2, cytosolic phospholipase to the annexin of of Ca2+-dependent binding to ANXA1 pleiotropic in and of is in and the function of ANXA1 is to of cell growth and of ANXA1 in many human and overexpression of ANXA1 in in growth suppression and/or apoptosis ANXA1 may mechanisms of the tumor-suppressive function of ANXA1, remain largely that ANXA1 the of cytosolic phospholipase A2 for of the function of ANXA1 in cell growth cPLA2 is an initiator enzyme of the arachidonic acid and in the of growth of many of of cPLA2 is to of binding of ANXA1 to cPLA2 to of by the binding of ANXA1 to is that ANXA1 is by the and that ANXA1 to an in the of the and of ANXA1 for cell growth by and the to the interaction ANXA1 and cPLA2 the ANXA1 is to the of ANXA1 and the of S100A11 Although for by the the and of the remain to that S100A11 is in On exposure of normal human keratinocytes to S100A11 was by and to the resulting in induction of growth inhibition was pathway was pathway was in cell that to indicate in to the the pathway is in and essential for the growth inhibition of NHK by the interaction of S100A11 with we the of and the and of ANXA1, inhibition of cPLA2 by ANXA1, and binding of ANXA1 to mechanistically in with the growth human cell and human cell and was in with and and in with NHK of the was to the and an human and and and of to of human S100A11 and ANXA1 in of of S100A11 by with by was by with and the the by the S100A11 and of to the function of S100A11 in S100A11 was by the and and the and to ANXA1 and of ANXA1 the of and an by with and by and we for of S100A11 in annexin A1 in to and human cPLA2 and was by and for human and and and of was was with and was was with of in and by in with ANXA1 ANXA1 was to with and with the by by with and an with an of and of by and to the and of by and and of ANXA1, and cPLA2 and on the of we binding S100A11 and S100A11 was by in binding Ca2+-dependent the of the of an S100A11 largely the of S100A11 with of S100A11 and binding to that of the S100A11 and cPLA2 by to the cell S100A11 to the the of cPLA2 to and by that the of the binding of ANXA1 to ANXA1 and cPLA2 of ANXA1 in NHK S100A11 and cPLA2 and of S100A11 an the cPLA2 S100A11 the binding of S100A11 to ANXA1 and cPLA2, S100A11 in to that of the in of ANXA1 by binding to S100A11 and of ANXA1 and of binding of ANXA1 to S100A11 and cPLA2 by NHK with and by with with an an is for an for cell ANXA1 was an with of NHK with in and with cleaved NHK with an was and for to of overexpression of S100A11 and ANXA1 on ANXA1 NHK in to that in cell was by with of is for the for we the of binding of ANXA1 to cPLA2 that was facilitated by cPLA2 was by with acid in of NHK with in of cPLA2 of S100A11 and ANXA1 the NHK the S100A11 of cPLA2 that of the of S100A11 on S100A11 with to binding to ANXA1 to inhibition of cPLA2 of ANXA1 the the to cPLA2 the of binding to S100A11 overexpression of of ANXA1 to cPLA2 to that in the of the of NHK was to largely on the arachidonic acid of cPLA2 and an by and was by arachidonic acid to the cPLA2 is an enzyme the arachidonic and arachidonic acid was to in growth of epidermal keratinocytes of cPLA2 which was by the cPLA2 of NHK with the of S100A11 and ANXA1 was with the of cPLA2 for the with S100A11 and was to of cPLA2 indicate that Ca2+-dependent of the the binding of ANXA1 to cPLA2 and that ANXA1 cPLA2 with of ANXA1 on of NHK to and of to S100A11 and NHK to ANXA1 on was in and of S100A11 and ANXA1 was and of ANXA1 S100A11 On exposure of NHK to was in of the that ANXA1 to S100A11 the of ANXA1 was with in the of S100A11 and cPLA2 by of ANXA1 in NHK and by acid to the the of the was to ANXA1 by of the was to that ANXA1 was cleaved solely the of in NHK on exposure to in of ANXA1 by was by of ANXA1, and of the on the cell with in the was to that of ANXA1 in with by On exposure of NHK to the signal with the the signal to the of the interaction S100A11 and ANXA1 in to binding to cPLA2, we of of S100A11 and ANXA1 NHK with S100A11 and ANXA1 and by with and NHK with overexpression of S100A11 ANXA1 binding to cPLA2, and overexpression of S100A11 for On exposure to ANXA1 was was by of the ANXA1 to by S100A11 to of S100A11 ANXA1 was that of ANXA1 is for indicate that on exposure of NHK to ANXA1 is and cleaved and that cleaved ANXA1 binding to S100A11 and to cPLA2, resulting in of the inhibition of cPLA2 that is in with the of cell growth by by of for ANXA1 for the of ANXA1, we binding to the the of with molecular of binding the and was in of the human was of ANXA1 by was of the of ANXA1 in of the binding of ANXA1 to S100A11 and cPLA2 by by function to ANXA1 to to of of ANXA1 in growth inhibition by of of ANXA1 by of was by to of the of for of ANXA1 of that to an of NHK with an and the and with of on of with NHK in with for and in for with and to for of of on the of NHK to NHK in to that in of is for of by of the NHK and to in for of to of was in NHK. to of on of and growth of NHK. of growth of NHK by in an for which in NHK in with and of ANXA1 of which was by of S100A11 is for growth suppression of NHK of S100A11 and cPLA2 by an that of and and of cPLA2 by in NHK to in to the and binding of ANXA1 to in the and the of cPLA2 on and of cPLA2 was in NHK with of with and of growth of NHK by NHK to in the for and with to NHK in for with an of and with the the in cell was by with NHK and to in an and acid to of of of ANXA1, and cPLA2 in we the of the growth ANXA1, and cPLA2 in human of cPLA2 to and in in growth of cPLA2 for growth of the cell and the was and ANXA1 was and cPLA2 was binding to ANXA1 and of an to and of ANXA1 was in and of for in of of ANXA1 in cell of ANXA1 was by an was by for the that of ANXA1 is an to the of to of in an and which is an of cell indicate that growth of is through of the in an of ANXA1, and cPLA2 in cell growth inhibition of by cPLA2 with cPLA2 for was to the to and in an was to of ANXA1, and cPLA2 in is to that in NHK. NHK in for with for for of of ANXA1 in NHK to and by with of of by in of and by with of in the S100A11 the function of ANXA1 and the arachidonic acid interaction with of S100A11 and ANXA1 binding to cPLA2 and suppression of cPLA2 activity, which is essential for the growth of NHK and of ANXA1, resulting in of binding to S100A11 and of function to cPLA2 we molecular mechanisms of ANXA1 links the and the arachidonic acid pathway through the interaction with ANXA1 with S100A11 to cPLA2 and On exposure to ANXA1 is by the and cleaved by resulting in S100A11 and cPLA2 and in of cPLA2, enzyme for growth is in to cleaved to the and and on the of and that ANXA1 was cleaved solely in NHK to and that the was by in the that cleaved ANXA1 was an in and was that ANXA1 to S100A11 in Ca2+-dependent of ANXA1 an the binding of ANXA1 to S100A11 of the binding on was in in which the of the of an S100A11 the binding in the of the binding an of S100A11 with ANXA1, and the of S100A11 NHK was to and the was ANXA1 and S100A11 in on and on binding the interaction and cPLA2 is to in the On the the enzyme of ANXA1, is that ANXA1 was by that to the Regulation of binding ANXA1 and S100A11 to in the Although the mechanisms to ANXA1 was to in and of the ANXA1 is by the in and on the with an ANXA1 in the and that in the may which is by and of growth of NHK by that S100A11 functions an essential for growth suppression of NHK by and S100A11 is by for the and induction of of on the of S100A11 to ANXA1 of S100A11 and binding to that of the in of NHK and of ANXA1 in the of may to of the and suppression of in NHK the and binding of ANXA1 to in the and of cPLA2, in NHK to of cPLA2 by in cell pathway with the growth of NHK in to with previous reports to that S100A11 for growth suppression of in the of in the and in the inhibition of cPLA2 through the binding to ANXA1 in the to in many of human and of ANXA1 cleaved in and to S100A11 in is that S100A11 was NHK on exposure to and that S100A11 in cell growth in and in evidence in that ANXA1 mechanistically links the growth signal pathway with cPLA2, an initiator enzyme of the arachidonic acid cascade, through interaction with that of the on molecular normal and and in in may for human and cell growth A1 ANXA1, annexin normal human epidermal growth growth cPLA2, cytosolic phospholipase ANXA1, annexin normal human epidermal growth growth cPLA2, cytosolic phospholipase to the annexin of of Ca2+-dependent binding to ANXA1 pleiotropic in and of is in and the function of ANXA1 is to of cell growth and of ANXA1 in many human and overexpression of ANXA1 in in growth suppression and/or apoptosis ANXA1 may mechanisms of the tumor-suppressive function of ANXA1, remain largely unknown. that ANXA1 the of cytosolic phospholipase A2 for of the function of ANXA1 in cell growth cPLA2 is an initiator enzyme of the arachidonic acid and in the of growth of many of of cPLA2 is to of binding of ANXA1 to cPLA2 to of by the binding of ANXA1 to is that ANXA1 is by the and that ANXA1 to an in the of the and of ANXA1 for cell growth by and the to the interaction ANXA1 and cPLA2 On the ANXA1 is to the of ANXA1 and the of S100A11 Although for by the the and of the remain to that S100A11 is in On exposure of normal human keratinocytes to S100A11 was by and to the resulting in induction of growth inhibition was pathway was pathway was in cell that to indicate in to the the pathway is in and essential for the growth inhibition of NHK by the interaction of S100A11 with we the of and the and of ANXA1, inhibition of cPLA2 by ANXA1, and binding of ANXA1 to mechanistically in with the growth human cell and human cell and was in with and and in with NHK of the was to the and an human and and and of to of human S100A11 and ANXA1 in of of S100A11 by with by was by with and the the by the S100A11 and of to the function of S100A11 in S100A11 was by the and and the and to ANXA1 and of ANXA1 the of and an by with and by and we for of S100A11 in annexin A1 in to and human cPLA2 and was by and for human and and and of was was with and was was with of in and by in with ANXA1 ANXA1 was to with and with the by by with and an with an of and of by and to the and of by and and in with the growth human cell and human cell and was in with and and in with NHK of the was to the and an human and and and of to of human S100A11 and ANXA1 in of of S100A11 by with by was by with and the the by the S100A11 and of to the function of S100A11 in S100A11 was by the and and the and to ANXA1 and of ANXA1 the of and an by with and by and we for of S100A11 in annexin A1 in to and human cPLA2 and was by and for human and and and of was was with and was was with of in and by in with ANXA1 ANXA1 was to with and with the by by with and an with an of and of by and to the and of by and and of ANXA1, and cPLA2 and on the of we binding S100A11 and S100A11 was by in binding Ca2+-dependent the of the of an S100A11 largely the of S100A11 with of S100A11 and binding to that of the S100A11 and cPLA2 by to the cell S100A11 to the the of cPLA2 to and by that the of the binding of ANXA1 to ANXA1 and cPLA2 of ANXA1 in NHK S100A11 and cPLA2 and of S100A11 an the cPLA2 S100A11 the binding of S100A11 to ANXA1 and cPLA2, S100A11 in to that of the in we the of binding of ANXA1 to cPLA2 that was facilitated by cPLA2 was by with acid in of NHK with in of cPLA2 of S100A11 and ANXA1 the NHK the S100A11 of cPLA2 that of the of S100A11 on S100A11 with to binding to ANXA1 to inhibition of cPLA2 of ANXA1 the the to cPLA2 the of binding to S100A11 overexpression of of ANXA1 to cPLA2 to that in the of the of NHK was to largely on the arachidonic acid of cPLA2 and an by and was by arachidonic acid to the cPLA2 is an enzyme the arachidonic and arachidonic acid was to in growth of epidermal keratinocytes of cPLA2 which was by the cPLA2 of NHK with the of S100A11 and ANXA1 was with the of cPLA2 for the with S100A11 and was to of cPLA2 indicate that Ca2+-dependent of the the binding of ANXA1 to cPLA2 and that ANXA1 cPLA2 with of ANXA1 on of NHK to and of to S100A11 and NHK to ANXA1 on was in and of S100A11 and ANXA1 was and of ANXA1 S100A11 On exposure of NHK to was in of the that ANXA1 to S100A11 the of ANXA1 was with in the of S100A11 and cPLA2 by of ANXA1 in NHK and by acid to the the of the was to ANXA1 by of the was to that ANXA1 was cleaved solely the of in NHK on exposure to in of ANXA1 by was by of ANXA1, and of the on the cell with in the was to that of ANXA1 in with by On exposure of NHK to the signal with the the signal to the of the interaction S100A11 and ANXA1 in to binding to cPLA2, we of of S100A11 and ANXA1 NHK with S100A11 and ANXA1 and by with and NHK with overexpression of S100A11 ANXA1 binding to cPLA2, and overexpression of S100A11 for On exposure to ANXA1 was was by of the ANXA1 to by S100A11 to of S100A11 ANXA1 was that of ANXA1 is for indicate that on exposure of NHK to ANXA1 is and cleaved and that cleaved ANXA1 binding to S100A11 and to cPLA2, resulting in of the inhibition of cPLA2 that is in with the of cell growth by by of for ANXA1 for the of ANXA1, we binding to the the of with molecular of binding the and was in of the human was of ANXA1 by was of the of ANXA1 in of the binding of ANXA1 to S100A11 and cPLA2 by by function to ANXA1 to to of of ANXA1 in growth inhibition by of of ANXA1 by of was by to of the of for of ANXA1 of that to an of NHK with an and the and with of on of with NHK in with for and in for with and to for of of on the of NHK to NHK in to that in of is for of by of the NHK and to in for of to of was in NHK. to of on of and growth of NHK. of growth of NHK by in an for which in NHK in with and of ANXA1 of which was by of S100A11 is for growth suppression of NHK of S100A11 and cPLA2 by an that of and and of cPLA2 by in NHK to in to the and binding of ANXA1 to in the and the of cPLA2 on and of cPLA2 was in NHK with of with and of growth of NHK by NHK to in the for and with to NHK in for with an of and with the the in cell was by with NHK and to in an and acid to of of of ANXA1, and cPLA2 in we the of the growth ANXA1, and cPLA2 in human of cPLA2 to and in in growth of cPLA2 for growth of the cell and the was and ANXA1 was and cPLA2 was binding to ANXA1 and of an to and of ANXA1 was in and of for in of of ANXA1 in cell of ANXA1 was by an was by for the that of ANXA1 is an to the of to of in an and which is an of cell indicate that growth of is through of the in an of ANXA1, and cPLA2 in cell growth inhibition of by cPLA2 with cPLA2 for was to the to and in an was to of ANXA1, and cPLA2 in is to that in NHK. NHK in for with for for of of ANXA1 in NHK to and by with of of by in of and by with of in the S100A11 the function of ANXA1 and the arachidonic acid interaction with of S100A11 and ANXA1 binding to cPLA2 and suppression of cPLA2 activity, which is essential for the growth of NHK and of ANXA1, resulting in of binding to S100A11 and of function to cPLA2 of ANXA1, and cPLA2 and on the of we binding S100A11 and S100A11 was by in binding Ca2+-dependent the of the of an S100A11 largely the of S100A11 with of S100A11 and binding to that of the S100A11 and cPLA2 by to the cell S100A11 to the the of cPLA2 to and by that the of the binding of ANXA1 to ANXA1 and cPLA2 of ANXA1 in NHK S100A11 and cPLA2 and of S100A11 an the cPLA2 S100A11 the binding of S100A11 to ANXA1 and cPLA2, S100A11 in to that of the in we the of binding of ANXA1 to cPLA2 that was facilitated by cPLA2 was by with acid in of NHK with in of cPLA2 of S100A11 and ANXA1 the NHK the S100A11 of cPLA2 that of the of S100A11 on S100A11 with to binding to ANXA1 to inhibition of cPLA2 of ANXA1 the the to cPLA2 the of binding to S100A11 overexpression of of ANXA1 to cPLA2 to that in the of the of NHK was to largely on the arachidonic acid of cPLA2 and an by and was by arachidonic acid to the cPLA2 is an enzyme the arachidonic and arachidonic acid was to in growth of epidermal keratinocytes of cPLA2 which was by the cPLA2 of NHK with the of S100A11 and ANXA1 was with the of cPLA2 for the with S100A11 and was to of cPLA2 indicate that Ca2+-dependent of the the binding of ANXA1 to cPLA2 and that ANXA1 cPLA2 with of ANXA1 on of NHK to and of to S100A11 and NHK to ANXA1 on was in and of S100A11 and ANXA1 was and of ANXA1 S100A11 On exposure of NHK to was in of the that ANXA1 to S100A11 the of ANXA1 was with in the of S100A11 and cPLA2 by of ANXA1 in NHK and by acid to the the of the was to ANXA1 by of the was to that ANXA1 was cleaved solely the of in NHK on exposure to in of ANXA1 by was by of ANXA1, and of the on the cell with in the was to that of ANXA1 in with by On exposure of NHK to the signal with the the signal to the of the interaction S100A11 and ANXA1 in to binding to cPLA2, we of of S100A11 and ANXA1 NHK with S100A11 and ANXA1 and by with and NHK with overexpression of S100A11 ANXA1 binding to cPLA2, and overexpression of S100A11 for On exposure to ANXA1 was was by of the ANXA1 to by S100A11 to of S100A11 ANXA1 was that of ANXA1 is for indicate that on exposure of NHK to ANXA1 is and cleaved and that cleaved ANXA1 binding to S100A11 and to cPLA2, resulting in of the inhibition of cPLA2 that is in with the of cell growth by by of for ANXA1 for the of ANXA1, we binding to the the of with molecular of binding the and was in of the human was of ANXA1 by was of the of ANXA1 in of the binding of ANXA1 to S100A11 and cPLA2 by by function to ANXA1 to to of of ANXA1 in growth inhibition by of of ANXA1 by of was by to of the of on of and growth of NHK. of growth of NHK by in an for which in NHK in with and of ANXA1 of which was by of S100A11 is for growth suppression of NHK of S100A11 and cPLA2 by an that of and and of cPLA2 by in NHK to in to the and binding of ANXA1 to in the and the of cPLA2 on and of cPLA2 was in NHK with of ANXA1, and cPLA2 in we the of the growth ANXA1, and cPLA2 in human of cPLA2 to and in in growth of cPLA2 for growth of the cell and the was and ANXA1 was and cPLA2 was binding to ANXA1 and of an to and of ANXA1 was in and of for in of of ANXA1 in cell of ANXA1 was by an was by for the that of ANXA1 is an to the of to of in an and which is an of cell indicate that growth of is through of the in an we molecular mechanisms of ANXA1 links the and the arachidonic acid pathway through the interaction with ANXA1 with S100A11 to cPLA2 and On exposure to ANXA1 is by the and cleaved by resulting in S100A11 and cPLA2 and in of cPLA2, enzyme for growth is in to cleaved to the and and on the of and that ANXA1 was cleaved solely in NHK to and that the was by in the that cleaved ANXA1 was an in and was that ANXA1 to S100A11 in Ca2+-dependent of ANXA1 an the binding of ANXA1 to S100A11 of the binding on was in in which the of the of an S100A11 the binding in the of the binding an of S100A11 with ANXA1, and the of S100A11 NHK was to and the was ANXA1 and S100A11 in on and on binding the interaction and cPLA2 is to in the On the the enzyme of ANXA1, is that ANXA1 was by that to the Regulation of binding ANXA1 and S100A11 to in the Although the mechanisms to ANXA1 was to in and of the ANXA1 is by the in and on the with an ANXA1 in the and that in the may which is by and of growth of NHK by that S100A11 functions an essential for growth suppression of NHK by and S100A11 is by for the and induction of of on the of S100A11 to ANXA1 of S100A11 and binding to that of the in of NHK and of ANXA1 in the of may to of the and suppression of in NHK the and binding of ANXA1 to in the and of cPLA2, in NHK to of cPLA2 by in cell pathway with the growth of NHK in to with previous reports to that S100A11 for growth suppression of in the of in the and in the inhibition of cPLA2 through the binding to ANXA1 in the to in many of human and of ANXA1 cleaved in and to S100A11 in is that S100A11 was NHK on exposure to and that S100A11 in cell growth in and in evidence in that ANXA1 mechanistically links the growth signal pathway with cPLA2, an initiator enzyme of the arachidonic acid cascade, through interaction with that of the on molecular normal and and in in may for human and cell growth we molecular mechanisms of ANXA1 links the and the arachidonic acid pathway through the interaction with ANXA1 with S100A11 to cPLA2 and On exposure to ANXA1 is by the and cleaved by resulting in S100A11 and cPLA2 and in of cPLA2, enzyme for growth is in ANXA1 to cleaved to the and and on the of and that ANXA1 was cleaved solely in NHK to and that the was by in the that cleaved ANXA1 was an in and was that ANXA1 to S100A11 in Ca2+-dependent of ANXA1 an the binding of ANXA1 to S100A11 of the binding on was in in which the of the of an S100A11 the binding in the of the binding an of S100A11 with ANXA1, and the of S100A11 NHK was to and the was Although ANXA1 and S100A11 in on and on binding the interaction and cPLA2 is to in the On the the enzyme of ANXA1, is that ANXA1 was by that to the Regulation of binding ANXA1 and S100A11 to in the Although the mechanisms to ANXA1 was to in and of the ANXA1 is by the in and on the with an ANXA1 in the and that in the may which is by and of growth of NHK by that S100A11 functions an essential for growth suppression of NHK by and S100A11 is by for the and induction of of on the of S100A11 to ANXA1 of S100A11 and binding to that of the in of NHK and of ANXA1 in the of may to of the and suppression of in NHK the and binding of ANXA1 to in the and of cPLA2, in NHK to of cPLA2 by in cell pathway with the growth of NHK in to with previous reports to that S100A11 for growth suppression of in the of in the and in the inhibition of cPLA2 through the binding to ANXA1 in the to in many of human and of ANXA1 cleaved in and to S100A11 in is that S100A11 was NHK on exposure to and that S100A11 in cell growth in and in evidence in that ANXA1 mechanistically links the growth signal pathway with cPLA2, an initiator enzyme of the arachidonic acid cascade, through interaction with that of the on molecular normal and and in in may for human and cell growth of and for in with with
24
Harry T. Haigler, David D. Schlaepfer, Wilson H. Burgess · Journal of Biological Chemistry · 1987 · 264 citations · Full text